Five things for pharma marketers to know: Tuesday, February 28, 2023
Billy Dunn to leave FDA; Irenic Capital urges Theravance to conduct review, add shareholder to board.
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Billy Dunn to leave FDA; Irenic Capital urges Theravance to conduct review, add shareholder to board.
The FDA’s Vaccine and Related Biological Products Advisory Committee convenes a two-day meeting today to consider recommending two new respiratory syncytial virus vaccinations for adults 60 years and older.
(Reuters) - The U.S. Food and Drug Administration neurosciences head Billy Dunn will retire from his role effective immediately, the health regulator ...
(Reuters) - The U.S. Food and Drug Administration neurosciences head Billy Dunn will retire from his role effective immediately, the health regulator ...